Prevalence, admission rates and hypoxia due to COVID-19 in patients with rheumatic disorders treated with targeted synthetic or biologic disease modifying antirheumatic drugs or methotrexate: a nationwide study from Iceland.
To access publisher's full text version of this article click on the hyperlink below
Published in: | Annals of the Rheumatic Diseases |
---|---|
Main Authors: | , , , , , |
Other Authors: | |
Format: | Article in Journal/Newspaper |
Language: | English |
Published: |
BMJ Publishing Group
2021
|
Subjects: | |
Online Access: | http://hdl.handle.net/2336/621869 https://doi.org/10.1136/annrheumdis-2020-219564 |
Summary: | To access publisher's full text version of this article click on the hyperlink below |
---|